“It takes too long.”
From kickoff to readout, timeline is the first concern we hear, on every call.
Time
Enrollment starts from an existing community with wearable baselines on file, not from a standing start.
Why Reputable
An enrolled participant community with wearable baselines already on file, IRB oversight, and one team from protocol to report. Here is why the timeline looks different, and why the rigor does not.
Schedule a Call
What we hear
Every conversation with a sponsor surfaces the same frustrations with how research usually gets done. Not with research itself. With what it costs them to get it.
From kickoff to readout, timeline is the first concern we hear, on every call.
Time
Enrollment starts from an existing community with wearable baselines on file, not from a standing start.
Budget is the second question, every time.
Money
Every study is scoped to your question, your timeline, and your budget. There is no one-size protocol and no one-size price.
Sponsors want research run for them, not another project to manage.
Energy
Our team handles protocol design, IRB submission, enrollment, data capture, analysis, and reporting. You set the direction. We carry the work.
The engine
Nothing about the method is abbreviated. The difference is what is already built before your study starts.
Health-engaged participants are already on the platform because they want to take part in research and track their own health. When a study opens, screening starts from an existing community of people who chose to be here.
Participants bring wearable history that can inform screening and baseline planning. The protocol defines the baseline measurements your study needs.
Daily check-ins, automated reminders, and the Heartbeats rewards program keep adherence visible in real time, for the whole study, not just week one.
IRB oversight is built into every pilot. The review pathway follows the study design. Speed never means skipping oversight.
What sets us apart
Visibility
You're not left wondering where your study stands. At pivotal endpoints throughout, our team sends a personalized breakdown of progress and outcomes: the numbers, and what they mean.
Methodology
Flexibility
Start with a pilot, run a full clinical study, or do both. Two offerings, one team, scoped to your question rather than forced into a template.
Connected evidence
Continuous wearables including Oura, Apple Watch, and Whoop, at-home labs with blood biomarkers processed through CLIA-certified labs, and validated surveys, joined per participant into a single dataset.
See everything we can measureHow it works
From kickoff to final report, with full visibility along the way.
Start the conversationOne call to define your question, endpoints, timeline, and budget. The design follows from those, not the other way around.
We draft the protocol, determine the appropriate review pathway, and manage IRB submission and review.
We screen and enroll from our existing participant community. Eligibility criteria target the people who actually use products like yours.
Wearable, lab, and survey data are collected on protocol cadence. We share strategic progress and outcome updates at pivotal endpoints and intervals across the study period.
Statistician-reviewed analysis, delivered with materials your team can put to work.
The deliverable
Results only matter if your organization can use them. Alongside the full statistical report, we translate the findings into the language your stakeholders actually speak, whether that is marketing review, retail partners, investors, or counsel.
See everything a full study deliversPilot studies test for signal on a smaller scope. Full clinical studies build publication-grade evidence. Some teams run one, some run both, and the scope follows your question.
Pilot study
A focused study on a smaller scope, built around the question you need to answer.
Pilot StudyFull clinical study
A full clinical study designed for publication-grade evidence, scoped to your question.
Full Clinical StudyOne call. We map the design to your question, your timeline, and your budget.